Pharma: Other News To Note

• The FDA approved an abbreviated new drug application for a generic equivalent to Chadds Ford, Pa.-based Endo Pharmaceuticals Inc.'s Lidoderm (lidocaine topical patch 5 percent) by Watson Laboratories Inc., a subsidiary of Watson Pharmaceuticals Inc., of Parsippany, N.J.